Arunjyoti Bio Ventures reports standalone net profit of Rs 0.03 crore in the December 2022 quarter

Arunjyoti Bio Ventures standalone net profit declines 30.77% in the June 2021 quarter

The creamy layer - amongst the top performing stocks

Seems to be overvalued vs the market average

Lagging behind the market in financials growth

Showing good signs of profitability & efficiency

Good time to consider, stock is not in the overbought zone

The stock has a moderate number of red flags

Arunjyoti Bio Ventures is engaged in trading equities and commodities, software development operations, and bio ventures.